Pattern of Hypomethylating Agents Use among Elderly Patients with Myelodysplastic Syndromes

Little is known about how hypomethylating agents (HMAs) have been adopted into the treatment of myelodysplastic syndromes (MDS). We conducted a population-based study to assess the use of HMAs among 4,416 MDS patients (age ≥66 years) who were diagnosed during 2001–2005 and followed up through the en...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Wang, Rong, Gross, Cary P., Maggiore, Ronald J., Halene, Stephanie, Soulos, Pamela R., Raza, Azra, Galili, Naomi, Ma, Xiaomei
Formato: Artigo
Idioma:Inglês
Publicado: 2010
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3114277/
https://ncbi.nlm.nih.gov/pubmed/21067809
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.leukres.2010.10.007
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares